Bay Area's Arcus Biosciences Scores $107M, Initiates Two Clinical Trials Post author:Sam Post published:November 12, 2017 Post category:BioPharma Now totaling $227M, Arcus Biosciences announced it had closed a $107M Series C financing. Source: BioSpace You Might Also Like Booming Blueprint to Expand Into Former GlaxoSmithKline Site May 3, 2017 Abpro Expands Senior Leadership Team And Announces Adam Mostafa As Chief Financial Officer January 31, 2017 FDA Calls Roche's Autism Drug a Breakthrough January 28, 2018
Abpro Expands Senior Leadership Team And Announces Adam Mostafa As Chief Financial Officer January 31, 2017